Suppr超能文献

[一种用于检测经ASTA-Z 7654体外处理后的骨髓中未成熟前体细胞的简单方法]

[A simple method for detecting immature precursors after in vitro bone marrow treatment with ASTA-Z 7654].

作者信息

Lamana M, Fernández-Rañada J M

机构信息

Servicio de Hematología, Hospital de la Princesa, Diego de León, Madrid.

出版信息

Sangre (Barc). 1991 Dec;36(6):501-3.

PMID:1812583
Abstract

Cyclophosphamide derivatives for in vitro use, such as mafosphamide L lysine (ASTA-Z 7654) are capable of removing residual leukaemic cells from the bone marrow used for autologous transplantation. ASTA-Z also removes committed stem cells detected in semi-solid cultures (CFU-GM). However, haemopoiesis is preserved by more immature progenitors, undetected in usual cultures but detectable in liquid culture of 21 days (MTC). After treating 15 normal bone marrow specimens with 100 microM ASTA-Z, CFU-GM cultures and medium-term cultures (MTC) are carried out. CFU-GM are cultured on the 21st day of incubation from the cell suspension of the MTC. The CFU-GM made the day of in vitro treatment (0.9 colonies/plate) reappear in the CFU-GM cultures performed on the 21st day of incubation of MTC (42 colonies/plate), although the figures attained in parallel controls without any treatment are not fully reached.

摘要

用于体外的环磷酰胺衍生物,如马磷酰胺L-赖氨酸(ASTA-Z 7654)能够从用于自体移植的骨髓中清除残留的白血病细胞。ASTA-Z还能清除在半固体培养物(CFU-GM)中检测到的定向干细胞。然而,造血功能由更不成熟的祖细胞维持,这些祖细胞在常规培养物中未被检测到,但在21天的液体培养(MTC)中可被检测到。用100微摩尔ASTA-Z处理15份正常骨髓标本后,进行CFU-GM培养和中期培养(MTC)。CFU-GM在MTC细胞悬液培养的第21天进行培养。尽管未进行任何处理的平行对照所达到的数值未被完全达到,但在MTC培养第21天进行的CFU-GM培养中,体外处理当天产生的CFU-GM(0.9个集落/平板)再次出现(42个集落/平板)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验